期刊文献+

表观遗传异常在肿瘤发生发展中的研究进展 被引量:3

The reserch progress on the aberrant epigenetic alterations in tumor development
下载PDF
导出
摘要 肿瘤的发生、发展与表观遗传异常改变密切相关,其中5-胞嘧啶碱基甲基化(5-m C)和RNA的N6-甲基腺苷(m-6-A)是常见并极其重要的表观改变,具有高度保守性,几乎存在于所有生物体中,参与调控基因组稳定和表达,在分化发育和生殖过程中起有重要作用。研究发现DNA和RNA的高甲基化表观修饰在恶性肿瘤的发生、发展和侵袭转移中起重要作用。但这一过程可被一些去甲基化酶逆转,其中DNA去甲基化酶TET(ten-eleven translocation)酶家族和异柠檬酸脱氢酶(IDH)可催化5-m C成为5-羟甲基胞嘧啶,而RNA去甲基化酶肥胖风险基因和ALKBH5可逆转RNA的m-6-A修饰。本文综述DNA与RNA甲基化的生物学特征和机制及其在肿瘤中功能的研究进展。 Tumor development is closely related to abnormal epigenetic changes. The 5 position of cytosine (5-mC) and RNA N6-methyladenosine (m-6-A), which exist in almost all organisms and highly conserved, are common and extremely important epigenetic change in the regulation of genomic stability, gene expression, differentiation, development and reproductive. The study has shown that aberrant epigenetic alterations, including DNA and RNA hypermethylated modification, played an important role in the invasion and metastasis of malignant tumor. However, it can be reversed by some dehydrogenase, such as ten-eleven translocation (TET) family and isocitrate dehydrogenase (IDH) which may convert 5-mC to 5-hydroxymethylcytosine (5-hmC), and RNA demethylase obesity risk gene, fat mass and obesity-associated enzyme and ALKBH5 can reverse m-6-A of RNA. This paper reviews the biological characteristics and mechanisms of DNA and RNA methylation as well as their function in tumor development.
出处 《上海医药》 CAS 2015年第16期9-13,共5页 Shanghai Medical & Pharmaceutical Journal
基金 国家自然科学基金资助项目(81172277 81272724) 国家杰出青年科学基金资助项目(81225019)
关键词 肿瘤表观遗传 5-羟甲基胞嘧啶 N6-甲基腺苷 tumor epigenetics 5-hydroxymethylcytosine N6-methyladenosine
  • 相关文献

参考文献3

二级参考文献113

  • 1Tate PH, Bird AP. Effects of DNA methylation on DNA-binding proteins and gene expression. Curr Opin Genet Dev 1993; 3:226-31. 被引量:1
  • 2Gehring M, Reik W, Henikoff S. DNA demethylation by DNA repair. Trends Genet 2009; 25:82-90. 被引量:1
  • 3Shi Y, Lan F, Matson C, et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004; 119:941-53. 被引量:1
  • 4Katoh M, Katoh M. Identification and characterization of human CXXC10 gene in silico. Int J Onco12004; 25:1193-9. 被引量:1
  • 5Ono R, Taki T, Taketani T, Taniwaki M, Kobayashi H, Hayashi Y. LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23). Cancer Res 2002; 62:4075- 4080. 被引量:1
  • 6Iyer LM, Tahiliani M, Rao A, Aravind L. Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids. Cell Cycle 2009; 8:1698-710. 被引量:1
  • 7Allen MD, Grummitt CG, Hilcenko C, et al. Solution structure of the nonmethyl-CpG-binding CXXC domain of the leukaemia-associated MLL histone methyltransferase. EMBO J 2006; 25:4503-12. 被引量:1
  • 8Jin S-G, Guo C, Pfeifer GP. GADD45A does not promote DNA demethylation. PLoS Genet 2008; 4:e 1000013. 被引量:1
  • 9Tahiliani M, Koh KP, Shen Y, et al. Conversion of 5-methyl- cytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009; 324:930-5. 被引量:1
  • 10Ito S, D'Alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 2010; 466:1129-1133. 被引量:1

共引文献352

同被引文献27

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部